ENTYVIOHOME Trademark

Trademark Overview


On Monday, October 1, 2018, a trademark application was filed for ENTYVIOHOME with the United States Patent and Trademark Office. The USPTO has given the ENTYVIOHOME trademark a serial number of 88138639. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, July 10, 2019. This trademark is owned by Millennium Pharmaceuticals, Inc.. The ENTYVIOHOME trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Patient relationship management services, namely, direct contact between medical patients and medical practitioners to coordinate and schedule infusion treatments; Health care services, namely, providing one-on-one information about treatment, support, counseling, and training to ulcerative colitis and Crohn's disease patients; health care and disease management services provided to patients, namely, monitoring and management of patients undergoing infusion treatments, including monitoring of infusion treatment, patient prescriptions and health data; collaborating with interdisciplinary team comprising the health care provider, members of the health care team administrative staff and patient to insure optimization of patient health and goals

Health care services, namely, home infusion of pharmaceuticals for the treatment of ulcerative colitis and Crohn's Disease
entyviohome

General Information


Serial Number88138639
Word MarkENTYVIOHOME
Filing DateMonday, October 1, 2018
Status601 - ABANDONED - EXPRESS
Status DateWednesday, July 10, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPatient relationship management services, namely, direct contact between medical patients and medical practitioners to coordinate and schedule infusion treatments; Health care services, namely, providing one-on-one information about treatment, support, counseling, and training to ulcerative colitis and Crohn's disease patients; health care and disease management services provided to patients, namely, monitoring and management of patients undergoing infusion treatments, including monitoring of infusion treatment, patient prescriptions and health data; collaborating with interdisciplinary team comprising the health care provider, members of the health care team administrative staff and patient to insure optimization of patient health and goals
Goods and ServicesHealth care services, namely, home infusion of pharmaceuticals for the treatment of ulcerative colitis and Crohn's Disease
Pseudo MarkENTY VIO HOME

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, October 9, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 9, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Wednesday, July 10, 2019ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Wednesday, July 10, 2019ABANDONMENT - EXPRESS MAILED
Tuesday, July 9, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Monday, January 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 14, 2019NON-FINAL ACTION E-MAILED
Monday, January 14, 2019NON-FINAL ACTION WRITTEN
Friday, January 11, 2019ASSIGNED TO EXAMINER
Tuesday, October 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 4, 2018NEW APPLICATION ENTERED IN TRAM